| Q37528911 | A comparison of two systems of patient immobilization for prostate radiotherapy |
| Q91762094 | A pilot study of the shapes of ablation lesions in the canine prostate by laser, radiofrequency and microwave and their clinical significance |
| Q36966420 | A population-based study comparing HRQoL among breast, prostate, and colorectal cancer survivors to propensity score matched controls, by cancer type, and gender. |
| Q30537734 | A preliminary exploration of the feasibility of offering men information about potential prostate cancer treatment options before they know their biopsy results |
| Q37243866 | Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way? |
| Q90569654 | Adherence and barriers to penile rehabilitation over 2 years following radical prostatectomy |
| Q38026501 | Advances in imaging and in non-surgical salvage treatments after radiorecurrence in prostate cancer: what does the oncologist, radiotherapist and radiologist need to know? |
| Q89948687 | All change in the prostate cancer diagnostic pathway |
| Q24186971 | Altered radiation fractionation schedules for clinically localised and locally advanced prostate cancer |
| Q36520468 | An economic analysis of conservative management versus active treatment for men with localized prostate cancer |
| Q30575084 | Bayesian latent-class mixed-effect hybrid models for dyadic longitudinal data with non-ignorable dropouts |
| Q34490592 | Bone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study. |
| Q37993802 | Can we prevent incontinence? ICI-RS 2011. |
| Q37826011 | Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening |
| Q53468715 | Cavernous nerve regeneration using acellular nerve grafts. |
| Q38033742 | Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid. |
| Q41283989 | Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer. |
| Q45767001 | Clinically relevant fatigue in recurrence-free prostate cancer survivors. |
| Q30452994 | Coagulation of human prostate volumes with MRI-controlled transurethral ultrasound therapy: results in gel phantoms. |
| Q35888211 | Comorbidities, treatment and ensuing survival in men with prostate cancer |
| Q37965553 | Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions |
| Q38162919 | Comparative effectiveness research in localized prostate cancer treatment |
| Q41833334 | Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer |
| Q47136394 | Comparisons of health-related quality of life among surgery and radiotherapy for localized prostate cancer: a systematic review and meta-analysis |
| Q86857237 | Complications after radical prostatectomy or radiotherapy for prostate cancer: results of a population-based, propensity score-matched analysis |
| Q41420388 | Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer |
| Q48237504 | Complications of curative radiation treatment for early prostate cancer. |
| Q40007049 | Cost-effectiveness of Prostate Health Index for prostate cancer detection |
| Q31143305 | Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy-a claims data analysis |
| Q37366369 | Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs. |
| Q30988028 | Data pooling and analysis to build a preliminary item bank: an example using bowel function in prostate cancer. |
| Q36111142 | Decision-making process reported by Medicare patients who had coronary artery stenting or surgery for prostate cancer |
| Q60920436 | Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study |
| Q43582044 | Development and validation of nomograms to predict the recovery of urinary continence after radical prostatectomy: comparisons between immediate, early, and late continence |
| Q38233280 | Development of clinical models for predicting erectile function after localized prostate cancer treatment. |
| Q35797092 | Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study |
| Q57699582 | Diffuse optical tomography to monitor the photocoagulation front during interstitial photothermal therapy: Numerical simulations and measurements in tissue-simulating phantoms |
| Q33798557 | Disclosure of diagnosis and treatment among early stage prostate cancer survivors |
| Q44603939 | Discussing quality-of-life issues with a patient newly diagnosed with prostate cancer |
| Q53152239 | Does "normal" aging imply urinary, bowel, and erectile dysfunction? A general population survey. |
| Q64116337 | Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial |
| Q88331460 | Early assessment of patient satisfaction and health-related quality of life following robot-assisted radical prostatectomy |
| Q34107347 | Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment |
| Q57105892 | Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes |
| Q51035093 | Economic evaluation of diagnostic localization following biochemical prostate cancer recurrence. |
| Q38682470 | Effect of radical prostatectomy surgeon volume on complication rates from a large population-based cohort |
| Q35566534 | Effects of a 1-week inpatient course including information, physical activity, and group sessions for prostate cancer patients |
| Q35603121 | Effects of tadalafil treatment after bilateral nerve-sparing radical prostatectomy: quality of life, psychosocial outcomes, and treatment satisfaction results from a randomized, placebo-controlled phase IV study |
| Q46196411 | Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance. |
| Q37647245 | Erectile dysfunction, masculinity, and psychosocial outcomes: a review of the experiences of men after prostate cancer treatment |
| Q36364403 | Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment |
| Q39317893 | Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study |
| Q22122725 | Exploiting Literature-derived Knowledge and Semantics to Identify Potential Prostate Cancer Drugs |
| Q36696018 | Facilitating Clinical Outcomes Assessment through the automated identification of quality measures for prostate cancer surgery |
| Q40547127 | Factors associated with current and severe physical side-effects after prostate cancer treatment: What men report |
| Q33559123 | Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1) |
| Q33551846 | Feasibility of 3.0T magnetic resonance imaging-guided laser ablation of a cadaveric prostate. |
| Q36348825 | Feasibility, acceptability, and preliminary efficacy of a technology-assisted psychosocial intervention for racially diverse men with advanced prostate cancer |
| Q53771735 | Five year expanded prostate cancer index composite-based quality of life outcomes after prostatectomy for localized prostate cancer. |
| Q57106512 | Genome-Based Classification and Therapy of Prostate Cancer |
| Q36075394 | Health related quality of life for men treated for localized prostate cancer with long-term followup |
| Q48083643 | Health-related quality of life following radical prostatectomy: long-term outcomes |
| Q81167878 | How could getting screened for prostate cancer hurt you? |
| Q44662154 | How does initial treatment choice affect short‐term and long‐term costs for clinically localized prostate cancer? |
| Q36392816 | How, why and when should urologists evaluate male sexual function? |
| Q44463145 | Identifying how and for whom cognitive-behavioral stress management improves emotional well-being among recent prostate cancer survivors |
| Q35245037 | Image-guided focal therapy for prostate cancer |
| Q38834153 | Image-guided ultrasound phased arrays are a disruptive technology for non-invasive therapy |
| Q48084274 | Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies |
| Q36133773 | Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: a population-based study. |
| Q37373089 | Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences |
| Q36520523 | Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions |
| Q42638418 | Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study |
| Q53864503 | Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. |
| Q37011906 | Increasing use of radical prostatectomy for nonlethal prostate cancer in Sweden |
| Q27308917 | Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy |
| Q38372741 | Integrated Care in Prostate Cancer (ICARE-P): Nonrandomized Controlled Feasibility Study of Online Holistic Needs Assessment, Linking the Patient and the Health Care Team |
| Q91690113 | Integrating PROMIS® computerized adaptive tests into a web-based intervention for prostate cancer |
| Q34268907 | Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer |
| Q35037541 | Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: long-term follow-up |
| Q42424518 | Interpositional Nerve Grafting of the Prostatic Plexus after Radical Prostatectomy |
| Q47428930 | Intimacy after prostate cancer: A brief couples' workshop is associated with improvements in relationship satisfaction |
| Q39665631 | Investigation of power and frequency for 3D conformal MRI-controlled transurethral ultrasound therapy with a dual frequency multi-element transducer |
| Q30436410 | Lack of comprehension of common prostate cancer terms in an underserved population |
| Q37019370 | Laparoscopic radical prostatectomy: contemporary comparison with open surgery |
| Q63365946 | Late gastrointestinal toxicity after radiation for prostate cancer |
| Q36406665 | Life after prostate cancer treatment: a mixed methods study of the experiences of men with sexual dysfunction and their partners |
| Q48416543 | Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer |
| Q37253743 | Localized prostate cancer in Norway, the United States, and Spain: between-country differences of variables before treatment among patients eligible for curative treatment |
| Q37224575 | Long term physical sequelae after adult-onset cancer |
| Q38937777 | Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer |
| Q37250946 | Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study |
| Q34197475 | Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial |
| Q30542816 | Long-term functional outcomes after treatment for localized prostate cancer |
| Q39399525 | Long-term health care costs for patients with prostate cancer: a population-wide longitudinal study in New South Wales, Australia |
| Q38754823 | Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade. |
| Q51911985 | Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. |
| Q84567489 | Longitudinal assessment of BMI in relation to ADT use among early stage prostate cancer survivors |
| Q42123483 | Longitudinal comparison of quality of life after real-time tumor-tracking intensity-modulated radiation therapy and radical prostatectomy in patients with localized prostate cancer |
| Q34644401 | Luteinising hormone-releasing hormone antagonists in prostate cancer therapy |
| Q34323815 | MR thermometry in the human prostate gland at 3.0T for transurethral ultrasound therapy |
| Q47695858 | MRI-compatible transurethral ultrasound system for the treatment of localized prostate cancer using rotational control |
| Q48335363 | MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies |
| Q56515368 | Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial |
| Q37935194 | Magnetic resonance spectroscopy: a promising tool for the diagnostics of human prostate cancer? |
| Q36395180 | Management of clinically localized prostate cancer by radical prostatectomy followed by watchful waiting |
| Q33978360 | Management of complications of prostate cancer treatment |
| Q36456152 | Management of the complications of external beam radiotherapy and brachytherapy. |
| Q81585851 | Marriage and ethnicity predict treatment in localized prostate carcinoma |
| Q37033117 | Measuring health-related quality of life consequences from primary treatment for early-stage prostate cancer |
| Q50917204 | Measuring patients' expectations regarding health-related quality-of-life outcomes associated with prostate cancer surgery or radiotherapy. |
| Q35740452 | Men's experience of erectile dysfunction after treatment for colorectal cancer: qualitative interview study |
| Q37126321 | Men's experience with sexual dysfunction post-rectal cancer treatment: a qualitative study |
| Q35141974 | Millon Behavioral Medicine Diagnostic (MBMD) Predicts Health-Related Quality of Life (HrQoL) over time among men treated for localized prostate cancer |
| Q55368624 | Mining Electronic Health Records to Extract Patient-Centered Outcomes Following Prostate Cancer Treatment. |
| Q36723934 | Mode of prostate cancer detection is associated with the psychological wellbeing of survivors: results from the PiCTure study |
| Q24601536 | Mortality results from a randomized prostate-cancer screening trial |
| Q37003074 | Multi-kernel graph embedding for detection, Gleason grading of prostate cancer via MRI/MRS |
| Q34231678 | Novel diagnostic biomarkers for prostate cancer |
| Q53211098 | Omissions in Urology Residency Training Regarding Sexual Dysfunction Subsequent to Prostate Cancer Treatment: Identifying a Need. |
| Q37074954 | Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification |
| Q26801000 | Optimal duration of androgen deprivation therapy following radiation therapy in intermediate- or high-risk nonmetastatic prostate cancer: A systematic review and metaanalysis |
| Q30845863 | Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial |
| Q79794781 | Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote |
| Q37225040 | Patient-reported 'ever had' and 'current' long-term physical symptoms after prostate cancer treatments |
| Q36896182 | Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy |
| Q36810072 | Patient-reported outcomes of cancer survivors in England 1-5 years after diagnosis: a cross-sectional survey |
| Q37081919 | Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experiment |
| Q47982004 | Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey |
| Q36993690 | Penile rehabilitation following radical prostatectomy: role of early intervention and chronic therapy |
| Q34151889 | Perceived stress mediates the effects of social support on health-related quality of life among men treated for localized prostate cancer |
| Q26773724 | Pharmacologic and surgical therapies for sexual dysfunction in male cancer survivors |
| Q35958199 | Physical activity, sedentary behavior, and health-related quality of life in prostate cancer survivors in the health professionals follow-up study |
| Q37144305 | Physical and psychological long-term and late effects of cancer |
| Q35672812 | Physician social networks and variation in prostate cancer treatment in three cities. |
| Q34055665 | Physician social networks and variation in rates of complications after radical prostatectomy |
| Q86932211 | Pilot Study Evaluating a Rat Model of Radiation-induced Erectile Dysfunction Using an Image-guided Microirradiator |
| Q40371982 | Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma |
| Q40067521 | Population-based survivorship research using cancer registries: a study of non-Hodgkin's lymphoma survivors |
| Q38217242 | Post-prostatectomy erectile dysfunction: contemporary approaches from a US perspective |
| Q52937150 | Postoperative radiotherapy for prostate cancer. |
| Q81204194 | Potent men undergoing radical prostatectomy: a prospective study measuring sexual health outcomes and the impact of erectile dysfunction treatments |
| Q36026045 | Predicting prostate cancer many years before diagnosis: how and why? |
| Q51899089 | Predicting utility ratings for joint health States from single health States in prostate cancer: empirical testing of 3 alternative theories. |
| Q39884284 | Prevalence of erectile dysfunction in men screened for prostate cancer |
| Q102141767 | Prevalence of post-prostatectomy erectile dysfunction and a review of the recommended therapeutic modalities |
| Q34065705 | Principles of cancer screening: lessons from history and study design issues |
| Q38807805 | Pros and cons of focal therapy for localised prostate cancer |
| Q46054276 | Prostate cancer and the increasing role of active surveillance |
| Q34314644 | Prostate cancer in young men: an important clinical entity. |
| Q33795089 | Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality |
| Q58134906 | Prostate cancer survivorship care in the Veterans Health Administration |
| Q46701216 | Prostate cancer treatment for economically disadvantaged men: a comparison of county hospitals and private providers |
| Q36014301 | Prostate cancer treatment. The case for radical prostatectomy |
| Q46900318 | Prostate cancer: epidemiology and health-related quality of life |
| Q37236443 | Prostate cancer: psychosocial implications and management |
| Q45926957 | Prostatic biopsies in selected men aged 75 years and older guide key clinical management decisions. |
| Q38370882 | Psychosocial perspectives on sexual recovery after prostate cancer treatment |
| Q47605334 | Purposeful normalization when caring for husbands recovering from prostate cancer |
| Q37686901 | Quality of Life and Sexual Health in the Aging of PCa Survivors |
| Q37539271 | Quality of care indicators for prostate cancer: progress toward consensus |
| Q40844364 | Quality of life after prostate cancer treatments in patients comparable at baseline. |
| Q33845220 | Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer |
| Q48055230 | Quality of life and satisfaction among prostate cancer patients followed in a dedicated survivorship clinic |
| Q30209897 | Quality of life and satisfaction with information after radical prostatectomy, radical external beam radiotherapy and postoperative radiotherapy: a long-term follow-up study |
| Q44978278 | Quality of life in men receiving radiotherapy and neo-adjuvant androgen deprivation for prostate cancer: results from a prospective longitudinal study |
| Q36520543 | Quality of life in men undergoing active surveillance for localized prostate cancer |
| Q36134201 | Quality of life in patients with localized prostate cancer |
| Q37444820 | Quality of life three years after diagnosis of localised prostate cancer: population based cohort study |
| Q34294102 | Quality-of-life effects of prostate-specific antigen screening. |
| Q51843148 | Quantitative analysis of 3-D conformal MRI-guided transurethral ultrasound therapy of the prostate: theoretical simulations. |
| Q39356209 | Radical Prostatectomy for High-risk Localized or Node-Positive Prostate Cancer: Removing the Primary. |
| Q34315605 | Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials |
| Q42720533 | Recurrent scrotal edema in a patient with radiation enteritis: A case report |
| Q35892380 | Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy |
| Q50887281 | Regret of treatment decision and its association with disease-specific quality of life following prostate cancer treatment. |
| Q39167790 | Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment |
| Q30252065 | Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening |
| Q40607482 | Risk of hospitalisation after primary treatment for prostate cancer |
| Q62778079 | Robotic-assisted vs. open radical prostatectomy: A machine learning framework for intelligent analysis of patient-reported outcomes from online cancer support groups |
| Q34090617 | Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and Progression |
| Q34817507 | Satisfaction with information used to choose prostate cancer treatment |
| Q26764960 | Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis |
| Q38869211 | Sexual Dysfunction in Young Adult Survivors of Childhood Cancer |
| Q28287655 | Sexual function in men and women with neurological disorders |
| Q36009944 | Sexual, irritative, and voiding outcomes, following stereotactic body radiation therapy for prostate cancer |
| Q33633253 | Simulation study on the heating of the surrounding anatomy during transurethral ultrasound prostate therapy: a 3D theoretical analysis of patient safety. |
| Q41913507 | Simultaneous vs staged treatment of urolithiasis in patients undergoing radical prostatectomy |
| Q37810318 | Six years' experience with high-intensity focused ultrasonography for prostate cancer: oncological outcomes using the new 'Stuttgart' definition for biochemical failure |
| Q44592685 | Small study finds that 3 years after prostate cancer treatment, men may report high quality of life and functioning |
| Q36059891 | Social and clinical predictors of prostate cancer treatment decisions among men in South Carolina |
| Q33974816 | State-level cancer quality assessment and research: building and sustaining the data infrastructure |
| Q36426682 | Stereotactic Body Radiotherapy for Clinically Localized Prostate Cancer: Toxicity and Biochemical Disease-Free Outcomes from a Multi-Institutional Patient Registry |
| Q48837209 | Stereotactic body radiotherapy: an emerging treatment approach for localized prostate cancer |
| Q94563067 | Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression |
| Q89017942 | Suitable sexual health care according to men with prostate cancer and their partners |
| Q37104386 | Survival following primary androgen deprivation therapy among men with localized prostate cancer |
| Q35883123 | Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer |
| Q45942167 | Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. |
| Q47650581 | Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. |
| Q35735012 | Survivorship: sexual dysfunction (male), version 1.2013 |
| Q37417093 | Symptom management strategies for men with early-stage prostate cancer: results from the Prostate Cancer Patient Education Program (PC PEP). |
| Q26746913 | Systematic Review of Focal Prostate Brachytherapy and the Future Implementation of Image-Guided Prostate HDR Brachytherapy Using MR-Ultrasound Fusion |
| Q35933229 | Targeted prostate biopsy and MR-guided therapy for prostate cancer |
| Q38677185 | The Effect of Targeted Therapy for Genitourinary Malignancies on Sexual Function and Fertility |
| Q34606240 | The Japanese guideline for prostate cancer screening |
| Q30641961 | The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study |
| Q48072037 | The association of long-term treatment-related side effects with cancer-specific and general quality of life among prostate cancer survivors. |
| Q34536430 | The effects of cancer and cancer treatments on male reproductive function |
| Q37406520 | The incidence and anatomy of accessory pudendal arteries as depicted on multidetector-row CT angiography: clinical implications of preoperative evaluation for laparoscopic and robot-assisted radical prostatectomy |
| Q34961830 | The potential role of stem cells in the treatment of urinary incontinence |
| Q37374206 | The psychosocial aspects of sexual recovery after prostate cancer treatment |
| Q36379715 | The relationship between clinical benefit and receipt of curative therapy for prostate cancer |
| Q36905275 | Three-piece inflatable penile prostheses can be safely implanted after radical prostatectomy through a transverse scrotal incision |
| Q47153456 | Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancer |
| Q40117678 | Treatment of early-stage prostate cancer among rural and urban patients |
| Q37457693 | Trends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000-2006. |
| Q34108870 | Updated counselling for the patient with prostate cancer |
| Q36450629 | Urinary adverse effects of pelvic radiotherapy |
| Q41039673 | Urinary quality of life outcomes in men who were treated with image-guided intensity-modulated radiation therapy for prostate cancer |
| Q36806625 | Usability evaluation of the interactive Personal Patient Profile-Prostate decision support system with African American men. |
| Q42664772 | Use of a validated quality of life questionnaire to assess sexual function following laparoscopic radical prostatectomy |
| Q48439178 | Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference |
| Q57282320 | Using patient-reported outcomes to assess and improve prostate cancer brachytherapy |
| Q48957582 | Utility and health-related quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy |
| Q36218353 | Validity testing of the stopwatch urine stream interruption test in radical prostatectomy patients |
| Q36983662 | Will focal therapy become a standard of care for men with localized prostate cancer? |
| Q57560933 | Written information material and availability of sexual health care for men experiencing sexual dysfunction after prostate cancer treatment: An evaluation of Dutch urology and radiotherapy departments |
| Q82335048 | [Erectile dysfunction after radical prostatectomy : patient information, contact persons, postoperative proerectile therapy] |
| Q87181757 | [Long-term quality of life after prostatectomy and percutaneous radiotherapy for localized prostate cancer] |
| Q83494892 | [Primary treatment for localized prostate cancer: evaluation of patients' quality of life] |
| Q57141377 | [Sexual dysfunction after curietherapy and external radiotherapy of the prostate for localized prostate cancer] |